Samuel Broder Sensei Biotherapeutics, Inc. (SNSE) insider trading activity

SNSE Quotes by TradingView

Samuel Broder is Director of Sensei Biotherapeutics, Inc.. Currently has a direct ownership of 8,932 shares of SNSE, which is worth approximately $4,733. The most recent transaction as insider was on Jul 10, 2023, when has been sold 4,466 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.93K
0% 3M change
0% 12M change
Total Value Held $4,733

Samuel Broder Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 10 2023
BUY
Grant, award, or other acquisition
-
4,466 Added 33.33%
8,932 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
4,466 Added 50.0%
4,466 Common Stock

Also insider at

ORIA
Orion Biotech Opportunities Corp. Financial Services
Director
SB

Samuel Broder

Director
Rockville, MD

Track Institutional and Insider Activities on SNSE

Follow Sensei Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNSE shares.

Notify only if

Insider Trading

Get notified when an Sensei Biotherapeutics, Inc. insider buys or sells SNSE shares.

Notify only if

News

Receive news related to Sensei Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNSE